Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Therapy (HCV)
INF-Alpha May Lower Cancer in Chronic HCV Patients
November 20th, 1995
Interferon-alpha improves liver function in patients with chronic active hepatitis C with cirrhosis, and may protect against hepatocellular carcinoma, according to a study from Japan. It has been shown that risk factors associated with hepatocellular carcinoma include hepatitis B virus (HBV) infection, especially in Africa and Southeast Asia. In Japan, however, the rate of HBsAg-positive patients with hepatocellular carcinoma is on the decline, but there is an increase in hepatocellular carcinomas associated with non-A, non-B hepatitis. "Circulating antibodies to hepatitis C virus (HCV) have been found in a high proportion of patients with non-A,...
Source: Cancer Weekly (1995-11-20)
|
